Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases
Portfolio Pulse from Vandana Singh
The European Commission has agreed with BioNTech (BNTX) and Pfizer (PFE) to amend their existing COVID-19 vaccine contract, allowing EU countries to reduce the number of doses purchased and extending the delivery deadline to 2026.
May 26, 2023 | 11:53 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
BioNTech's amended vaccine contract with the EU allows reduced purchases and extends the delivery deadline to 2026.
The amended contract allows EU countries to reduce the number of doses purchased, which may lead to lower revenues for BioNTech. However, the extended delivery deadline to 2026 provides a longer timeframe for vaccine sales, potentially offsetting the impact of reduced purchases.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50
NEUTRAL IMPACT
Pfizer's amended vaccine contract with the EU allows reduced purchases and extends the delivery deadline to 2026.
The amended contract allows EU countries to reduce the number of doses purchased, which may lead to lower revenues for Pfizer. However, the extended delivery deadline to 2026 provides a longer timeframe for vaccine sales, potentially offsetting the impact of reduced purchases.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 50